Contemporary Prognostic Model for Renal Cell Carcinoma: Is it Time for Biomarkers?

Affiliations

¹ The Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: spate167@jhmi.edu.
² The Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA.

Editorial

Sunil H Patel et al. Eur Urol. 2021 Jul.

. 2021 Jul;80(1):32-33.

doi: 10.1016/j.eururo.2021.04.019. Epub 2021 Apr 30.

¹ The Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: spate167@jhmi.edu.
² The Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA.

No abstract available

Comment on

Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
Correa AF, Jegede OA, Haas NB, Flaherty KT, Pins MR, Adeniran A, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG. Correa AF, et al. Eur Urol. 2021 Jul;80(1):20-31. doi: 10.1016/j.eururo.2021.02.025. Epub 2021 Mar 9. Eur Urol. 2021. PMID: 33707112 Free PMC article.